Topical Recombinant Human Epidermal Growth Factor for Oral Mucositis Induced by Intensive Chemotherapy with Hematopoietic Stem Cell Transplantation: Final Analysis of a Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial

The aim of this study was to evaluate the efficacy and safety of recombinant human epidermal growth factor (rhEGF) oral spray for oral mucositis (OM) induced by intensive chemotherapy with hematopoietic stem cell transplantation. In this phase 2 study, patients were randomized to either rhEGF (50 mi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Kim, Ji-Won, Kim, Myeong Gyu, Lee, Hyun Jung, Koh, Youngil, Kwon, Ji-Hyun, Kim, Inho, Park, Seonyang, Kim, Byoung Kook, Oh, Jung Mi, Kim, Kyung Im, Yoon, Sung-Soo
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2017
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5207736/
https://ncbi.nlm.nih.gov/pubmed/28045958
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0168854
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados